Sahakian, L.; Robinson, A.M.; Sahakian, L.; Stavely, R.; Kelley, M.R.; Nurgali, K.
APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease. Biomolecules 2023, 13, 1569.
https://doi.org/10.3390/biom13111569
AMA Style
Sahakian L, Robinson AM, Sahakian L, Stavely R, Kelley MR, Nurgali K.
APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease. Biomolecules. 2023; 13(11):1569.
https://doi.org/10.3390/biom13111569
Chicago/Turabian Style
Sahakian, Lauren, Ainsley M. Robinson, Linda Sahakian, Rhian Stavely, Mark R. Kelley, and Kulmira Nurgali.
2023. "APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease" Biomolecules 13, no. 11: 1569.
https://doi.org/10.3390/biom13111569
APA Style
Sahakian, L., Robinson, A. M., Sahakian, L., Stavely, R., Kelley, M. R., & Nurgali, K.
(2023). APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease. Biomolecules, 13(11), 1569.
https://doi.org/10.3390/biom13111569